AMAG Pharmaceuticals, Inc. (AMAG) is an American pharmaceutical company developing products that treat iron deficiency anemia (IDA) in adult patients. The company is a publicly traded company listed on NASDAQ under the symbol "AMAG".
Reported before open yesterday (5/3/16) Earnings: EPS $0.94 Revenue $109.3M Estimates: EPS $1.11 Revenue $123M Down 14.21% yesterday